Related Articles
More than 45% of A549 and H446 cells are cancer initiating cells: Evidence from cloning and tumorigenic analyses
Targeting lung cancer initiating cells by all‑trans retinoic acid‑loaded lipid‑PLGA nanoparticles with CD133 aptamers
The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics
The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer
Dual‑targeting nanomicelles with CD133 and CD44 aptamers for enhanced delivery of gefitinib to two populations of lung cancer‑initiating cells